| Year |
Citation |
Score |
| 2023 |
Chirokoff V, Dupuy M, Abdallah M, Fatseas M, Serre F, Auriacombe M, Misdrahi D, Berthoz S, Swendsen J, Sullivan EV, Chanraud S. Craving dynamics and related cerebral substrates predict timing of use in alcohol, tobacco, and cannabis use disorders. Addiction Neuroscience. 9. PMID 38389954 DOI: 10.1016/j.addicn.2023.100138 |
0.31 |
|
| 2023 |
David JC, Fonte D, Sutter-Dallay AL, Auriacombe M, Serre F, Rascle N, Loyal D. The stigma of smoking among women: A systematic review. Social Science & Medicine (1982). 340: 116491. PMID 38096599 DOI: 10.1016/j.socscimed.2023.116491 |
0.599 |
|
| 2023 |
Sanchez-Ortuno MM, Pecune F, Coelho J, Micoulaud-Franchi JA, Salles N, Auriacombe M, Serre F, Levavasseur Y, de Sevin E, Sagaspe P, Philip P. Predictors of users' adherence to a fully automated digital intervention to manage insomnia complaints. Journal of the American Medical Informatics Association : Jamia. PMID 37672004 DOI: 10.1093/jamia/ocad163 |
0.623 |
|
| 2023 |
Chapron SA, Kervran C, Da Rosa M, Fournet L, Shmulewitz D, Hasin D, Denis C, Collombat J, Monsaingeon M, Fatseas M, Gatta-Cherifi B, Serre F, Auriacombe M. Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample. Drug and Alcohol Dependence. 251: 110937. PMID 37666092 DOI: 10.1016/j.drugalcdep.2023.110937 |
0.792 |
|
| 2023 |
Dora J, Piccirillo M, Foster KT, Arbeau K, Armeli S, Auriacombe M, Bartholow B, Beltz AM, Blumenstock SM, Bold K, Bonar EE, Braitman A, Carpenter RW, Creswell KG, De Hart T, et al. The daily association between affect and alcohol use: A meta-analysis of individual participant data. Psychological Bulletin. 149: 1-24. PMID 37560174 DOI: 10.1037/bul0000387 |
0.639 |
|
| 2023 |
Serre F, Moriceau S, Donnadieu L, Forcier C, Garnier H, Alexandre JM, Dupuy L, Philip P, Levavasseur Y, De Sevin E, Auriacombe M. The Craving-Manager smartphone app designed to diagnose substance use/addictive disorders, and manage craving and individual predictors of relapse: a study protocol for a multicenter randomized controlled trial. Frontiers in Psychiatry. 14: 1143167. PMID 37255691 DOI: 10.3389/fpsyt.2023.1143167 |
0.685 |
|
| 2023 |
Gauld C, Baillet E, Micoulaud-Franchi JA, Kervran C, Serre F, Auriacombe M. The centrality of craving in network analysis of five substance use disorders. Drug and Alcohol Dependence. 245: 109828. PMID 36868091 DOI: 10.1016/j.drugalcdep.2023.109828 |
0.683 |
|
| 2022 |
Morawetz C, Berboth S, Chirokoff V, Chanraud S, Misdrahi D, Serre F, Auriacombe M, Fatseas M, Swendsen J. Mood Variability, Craving, and Substance Use Disorders: From Intrinsic Brain Network Connectivity to Daily Life Experience. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 36775712 DOI: 10.1016/j.bpsc.2022.11.002 |
0.758 |
|
| 2022 |
Jakubiec L, Chirokoff V, Abdallah M, Sanz-Arigita E, Dupuy M, Swendsen J, Berthoz S, Gierski F, Guionnet S, Misdrahi D, Serre F, Auriacombe M, Fatseas M. The Executive Functioning Paradox in Substance Use Disorders. Biomedicines. 10. PMID 36359247 DOI: 10.3390/biomedicines10112728 |
0.779 |
|
| 2022 |
Stevens N, Martin-Fernandez J, Moriceau S, Serre F, Auriacombe M, Cambon L. Realist evaluation of three programmes aimed at reducing harm and risks associated with alcohol consumption in the Nouvelle Aquitaine region of France: the ECIAE study protocol. Bmj Open. 12: e057928. PMID 36207037 DOI: 10.1136/bmjopen-2021-057928 |
0.624 |
|
| 2022 |
Martin-Fernandez J, Stevens N, Moriceau S, Serre F, Blanc H, Latourte E, Auriacombe M, Cambon L. Realist evaluation of the impact, viability and transferability of an alcohol harm reduction support programme based on mental health recovery: the Vitae study protocol. Bmj Open. 12: e065361. PMID 35953259 DOI: 10.1136/bmjopen-2022-065361 |
0.661 |
|
| 2022 |
Boudard M, Alexandre JM, Kervran C, Jakubiec L, Shmulewitz D, Hasin D, Fournet L, Rassis C, Claverie P, Serre F, Auriacombe M. Item Response Theory Analyses of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Criteria Adapted to Screen Use Disorder: Exploratory Survey. Journal of Medical Internet Research. 24: e31803. PMID 35896018 DOI: 10.2196/31803 |
0.637 |
|
| 2022 |
Jean FAM, Arsandaux J, Montagni I, Collet O, Fatséas M, Auriacombe M, Ramos-Quiroga JA, Côté SM, Tzourio C, Galéra C. Attention deficit hyperactivity disorder symptoms and cannabis use after one year among students of the i-Share cohort. European Psychiatry : the Journal of the Association of European Psychiatrists. 1-18. PMID 35348052 DOI: 10.1192/j.eurpsy.2022.14 |
0.581 |
|
| 2022 |
Lambert L, Serre F, Thirioux B, Jaafari N, Roux P, Jauffret-Roustide M, Lalanne L, Daulouède JP, Auriacombe M. Link Between Perception of Treatment Need and Craving Reports in Addiction. Frontiers in Psychiatry. 12: 790203. PMID 35173637 DOI: 10.3389/fpsyt.2021.790203 |
0.639 |
|
| 2022 |
Loyal D, Sutter AL, Auriacombe M, Serre F, Rascle N. The Pregnant Smoker Stigma Scale - Public Stigma (P3S-PS): development and validation in general French population. Women & Health. 62: 157-167. PMID 35068351 DOI: 10.1080/03630242.2022.2030449 |
0.611 |
|
| 2021 |
Loyal D, Sutter AL, Auriacombe M, Serre F, Calcagni N, Rascle N. Stigma Attached to Smoking Pregnant Women: A Qualitative Insight in the General French Population. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 34546357 DOI: 10.1093/ntr/ntab190 |
0.595 |
|
| 2021 |
Auriacombe M, Fournet L, Dupuy L, Micoulaud-Franchi JA, de Sevin E, Moriceau S, Baillet E, Alexandre JM, Serre F, Philip P. Effectiveness and Acceptance of a Smartphone-Based Virtual Agent Screening for Alcohol and Tobacco Problems and Associated Risk Factors During COVID-19 Pandemic in the General Population. Frontiers in Psychiatry. 12: 693687. PMID 34335332 DOI: 10.3389/fpsyt.2021.693687 |
0.679 |
|
| 2021 |
Dupuy M, Abdallah M, Swendsen J, N'Kaoua B, Chanraud S, Schweitzer P, Fatseas M, Serre F, Barse E, Auriacombe M, Misdrahi D. Real-time cognitive performance and positive symptom expression in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. PMID 34287696 DOI: 10.1007/s00406-021-01296-2 |
0.725 |
|
| 2021 |
Bahadoor R, Alexandre JM, Fournet L, Gellé T, Serre F, Auriacombe M. Inventory and Analysis of Controlled Trials of Mobile Phone Applications Targeting Substance Use Disorders: A Systematic Review. Frontiers in Psychiatry. 12: 622394. PMID 33692708 DOI: 10.3389/fpsyt.2021.622394 |
0.688 |
|
| 2020 |
Philip P, Dupuy L, Morin CM, de Sevin E, Bioulac S, Taillard J, Serre F, Auriacombe M, Micoulaud-Franchi JA. Smartphone-Based Virtual Agents to Help the General Population Concerned by Sleep Complaints During COVID-19 Confinement: A Feasibility Study. Journal of Medical Internet Research. PMID 33264099 DOI: 10.2196/24268 |
0.61 |
|
| 2020 |
Kervran C, Shmulewitz D, Serre F, Stohl M, Denis C, Hasin D, Auriacombe M. Item Response Theory analyses of DSM-5 substance use disorder criteria in French outpatient addiction clinic participants. How much is craving special? Drug and Alcohol Dependence. 212: 108036. PMID 32464467 DOI: 10.1016/J.Drugalcdep.2020.108036 |
0.778 |
|
| 2019 |
Benchebra L, Alexandre JM, Dubernet J, Fatséas M, Auriacombe M. [Gambling and Gaming disorders and physical health of players: A critical review of the literature]. Presse Medicale (Paris, France : 1983). PMID 31767247 DOI: 10.1016/J.Lpm.2019.10.014 |
0.613 |
|
| 2019 |
Auriacombe M, Roux P, Briand Madrid L, Kirchherr S, Kervran C, Chauvin C, Gutowski M, Denis C, Carrieri MP, Lalanne L, Jauffret-Roustide M. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol. Bmj Open. 9: e023683. PMID 30796121 DOI: 10.1136/Bmjopen-2018-023683 |
0.565 |
|
| 2019 |
Micoulaud-Franchi J, Dupuy L, Moriceau S, Auriacombe M, Philip P. 0922 Embodied Conversational Agents Are Highly Accepted to Diagnose Psychiatric Disorders among Patients Suffering from Sleep Disorders Sleep. 42: A370-A371. DOI: 10.1093/Sleep/Zsz067.920 |
0.329 |
|
| 2019 |
Leouzon H, Alexandre J, Fatséas M, Auriacombe M. L’addiction aux jeux vidéo dans le DSM-5, controverses et réponses relatives à son diagnostic et sa définition Annales MéDico-Psychologiques, Revue Psychiatrique. 177: 610-623. DOI: 10.1016/J.Amp.2019.03.013 |
0.6 |
|
| 2018 |
Auriacombe M, Moriceau S, Serre F, Denis C, Micoulaud-Franchi JA, de Sevin E, Bonhomme E, Bioulac S, Fatseas M, Philip P. Development and validation of a virtual agent to screen tobacco and alcohol use disorders. Drug and Alcohol Dependence. 193: 1-6. PMID 30321739 DOI: 10.1016/J.Drugalcdep.2018.08.025 |
0.801 |
|
| 2018 |
Bouvard A, Dupuy M, Schweitzer P, Revranche M, Fatseas M, Serre F, Misdrahi D, Auriacombe M, Swendsen J. Feasibility and validity of mobile cognitive testing in patients with substance use disorders and healthy controls. The American Journal On Addictions. 27: 553-556. PMID 30260085 DOI: 10.1111/Ajad.12804 |
0.773 |
|
| 2018 |
Lemasson M, Rochette L, Galvão F, Poulet E, Lacroix A, Lecompte M, Auriacombe M, Patry S, Haesebaert F. Pertinence of Titration and Age-Based Dosing Methods for Electroconvulsive Therapy: An International Retrospective Multicenter Study. The Journal of Ect. PMID 29794554 DOI: 10.1097/Yct.0000000000000508 |
0.541 |
|
| 2018 |
Dupouy J, Vergnes A, Laporte C, Kinouani S, Auriacombe M, Oustric S, Rougé Bugat ME. Intensity of previous teaching but not diagnostic skills influences stigmatization of patients with substance use disorder by general practice residents. A vignette study among French final-year residents in general practice. The European Journal of General Practice. 24: 160-166. PMID 29792534 DOI: 10.1080/13814788.2018.1470239 |
0.364 |
|
| 2018 |
Fatseas M, Serre F, Swendsen J, Auriacombe M. Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study. Drug and Alcohol Dependence. 187: 242-248. PMID 29684892 DOI: 10.1016/J.Drugalcdep.2018.03.008 |
0.791 |
|
| 2018 |
Serre F, Fatseas M, Denis C, Swendsen J, Auriacombe M. Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: Commonalities and specificities across substances. Addictive Behaviors. PMID 29428330 DOI: 10.1016/J.Addbeh.2018.01.041 |
0.81 |
|
| 2018 |
Dupuy M, Misdrahi D, N’Kaoua B, Tessier A, Bouvard A, Schweitzer P, Auriacombe M, Serre F, Fatseas M, Swendsen J. Mobile cognitive testing in patients with schizophrenia: A controlled study of feasibility and validity Journal De ThéRapie Comportementale Et Cognitive. 28: 204-213. DOI: 10.1016/J.Jtcc.2018.02.002 |
0.751 |
|
| 2018 |
Auriacombe M, Fatséas M, Daulouède J, Tignol J. Le craving et nouvelle clinique de l’addiction : une perspective simplifiée et opérationnelle Annales MéDico-Psychologiques, Revue Psychiatrique. 176: 746-749. DOI: 10.1016/J.Amp.2018.08.014 |
0.574 |
|
| 2017 |
Dematteis M, Auriacombe M, D'Agnone O, Somaini L, Szerman N, Littlewood R, Alam F, Alho H, Benyamina A, Bobes J, Daulouede JP, Leonardi C, Maremmani I, Torrens M, Walcher S, et al. Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus. Expert Opinion On Pharmacotherapy. 18: 1987-1999. PMID 29183228 DOI: 10.1080/14656566.2017.1409722 |
0.366 |
|
| 2017 |
Dupouy J, Palmaro A, Fatséas M, Auriacombe M, Micallef J, Oustric S, Lapeyre-Mestre M. Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study. Annals of Family Medicine. 15: 355-358. PMID 28694272 DOI: 10.1370/Afm.2098 |
0.611 |
|
| 2017 |
Bouvard A, Dupuy M, Chevalier M, Jakubiec L, Fatseas M, Serre F, Hurmic H, Revranche M, Misdrahi D, Auriacombe M, Swendsen J. Feasibility and validity of mobile cognitive testing in patients with substance use disorders European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31890-4 |
0.773 |
|
| 2017 |
Dupouy J, Palmaro A, Fatséas M, Auriacombe M, Micallef J, Oustric S, Lapeyre-Mestre M. Mortalité associée aux périodes sous et hors traitement par buprénorphine Therapies. 72: 164. DOI: 10.1016/J.Therap.2016.11.041 |
0.58 |
|
| 2017 |
Techer L, Alexandre J, Mété D, Auriacombe M, Fatseas M. Addictive behaviors and psychiatric comorbidities of incarcerated women in a French overseas territory Drug and Alcohol Dependence. 171: e201. DOI: 10.1016/J.Drugalcdep.2016.08.549 |
0.598 |
|
| 2017 |
Serre F, Fatseas M, Swendsen J, Auriacombe M. How psychiatric comorbidity and mood states influence craving and substance use in daily life? An ecological momentary assessment study in patients with alcohol, tobacco, cannabis and heroin use disorders Drug and Alcohol Dependence. 171: e187. DOI: 10.1016/J.Drugalcdep.2016.08.513 |
0.795 |
|
| 2017 |
Fonseca F, Torrens M, Farre M, Green JL, Maremmani I, Guareschi M, Auriacombe M, Scherbaum N, Clausen T, Hill D, Dart RC. Patterns of prescription drug use in Spain: The European opioid treatment patient survey Drug and Alcohol Dependence. 171: e64. DOI: 10.1016/J.Drugalcdep.2016.08.185 |
0.321 |
|
| 2017 |
Fatseas M, Henry M, da Rosa MAC, Collombat J, Gregoire A, Kervran C, Cherifi B, Auriacombe M. Eating disorder, food addiction and associated factors in obese patients Drug and Alcohol Dependence. 171: e62. DOI: 10.1016/J.Drugalcdep.2016.08.180 |
0.614 |
|
| 2017 |
Denis CM, da Rosa MAC, Serre F, Kervran C, Henry M, Cherifi B, Auriacombe M, Fatseas M. Are DSM-5 criteria for sud transferable to food addiction? IRT analysis for alcohol, tobacco, cannabis, opiate and food addiction in a clinical sample Drug and Alcohol Dependence. 171: e52. DOI: 10.1016/J.Drugalcdep.2016.08.155 |
0.751 |
|
| 2017 |
Auriacombe M, Alexandre J, Dubernet J, Tanguy J, Fatseas M. Contribution of e-learning to addiction teaching: A successful experience at the university of bordeaux, France Drug and Alcohol Dependence. 171: e12. DOI: 10.1016/J.Drugalcdep.2016.08.048 |
0.557 |
|
| 2016 |
Fatséas M, Hurmic H, Serre F, Debrabant R, Daulouède JP, Denis C, Auriacombe M. Addiction severity pattern associated with adult and childhood Attention Deficit Hyperactivity Disorder (ADHD) in patients with addictions. Psychiatry Research. PMID 27842945 DOI: 10.1016/J.Psychres.2016.10.071 |
0.801 |
|
| 2016 |
Fatseas M, Kervran C, Auriacombe M. [Sleep disorders and addictions: Impact on quality of life and relapse vulnerability]. Presse Medicale (Paris, France : 1983). 45: 1164-1169. PMID 26970937 DOI: 10.1016/J.Lpm.2016.01.022 |
0.619 |
|
| 2016 |
Kaye S, Ramos-Quiroga JA, van de Glind G, Levin FR, Faraone SV, Allsop S, Degenhardt L, Moggi F, Barta C, Konstenius M, Franck J, Skutle A, Bu ET, Koeter MW, Demetrovics Z, ... ... Auriacombe M, et al. Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers. Journal of Attention Disorders. PMID 26922805 DOI: 10.1177/1087054716629217 |
0.651 |
|
| 2016 |
Petry NM, Rehbein F, Gentile DA, Lemmens JS, Rumpf HJ, Mößle T, Bischof G, Tao R, Fung DS, Borges G, Auriacombe M, González-Ibáñez A, Tam P, O'Brien CP. Griffiths et al.'s comments on the international consensus statement of internet gaming disorder: furthering consensus or hindering progress? Addiction (Abingdon, England). 111: 175-8. PMID 26669531 DOI: 10.1111/Add.13189 |
0.305 |
|
| 2016 |
Denis C, Fatséas M, Beltran V, Serre F, Alexandre JM, Debrabant R, Daulouède JP, Auriacombe M. Usefulness and validity of the modified Addiction Severity Index: A focus on alcohol, drugs, tobacco, and gambling. Substance Abuse. 37: 168-75. PMID 26110463 DOI: 10.1080/08897077.2015.1036334 |
0.823 |
|
| 2016 |
Denis C, Fatséas M, Beltran V, Serre F, Alexandre JM, Debrabant R, Daulouède JP, Auriacombe M. Usefulness and validity of the modified Addiction Severity Index: A focus on alcohol, drugs, tobacco, and gambling Substance Abuse. 37: 168-175. DOI: 10.1080/08897077.2015.1036334 |
0.788 |
|
| 2016 |
Auriacombe M, Debrabant R, Kervran C, Serre F, Taillard J, Philip P, Denis C, Fatséas M. Addiction et troubles du sommeil : craving, rythmes circadiens. Une mise au point MéDecine Du Sommeil. 13: 91-99. DOI: 10.1016/J.Msom.2016.04.004 |
0.761 |
|
| 2015 |
Skutle A, Bu ETH, Jellestad FK, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, Auriacombe M, et al. Early developmental, temperamental and educational problems in 'substance use disorder' patients with and without ADHD. Does ADHD make a difference? Addictive Behaviors Reports. 2: 13-18. PMID 29531989 DOI: 10.1016/J.Abrep.2015.03.001 |
0.625 |
|
| 2015 |
Kervran C, Fatséas M, Serre F, Taillard J, Beltran V, Leboucher J, Debrabant R, Alexandre JM, Daulouède JP, Philip P, Auriacombe M. Association between morningness/eveningness, addiction severity and psychiatric disorders among individuals with addictions. Psychiatry Research. 229: 1024-30. PMID 26250146 DOI: 10.1016/J.Psychres.2015.05.026 |
0.789 |
|
| 2015 |
Wapp M, van de Glind G, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Skutle A, Bu ET, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, ... Auriacombe M, et al. Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study. European Addiction Research. 21: 188-94. PMID 25832736 DOI: 10.1159/000371724 |
0.652 |
|
| 2015 |
Fatseas M, Serre F, Alexandre JM, Debrabant R, Auriacombe M, Swendsen J. Craving and substance use among patients with alcohol, tobacco, cannabis or heroin addiction: a comparison of substance- and person-specific cues. Addiction (Abingdon, England). 110: 1035-42. PMID 25688760 DOI: 10.1111/Add.12882 |
0.783 |
|
| 2015 |
Serre F, Fatseas M, Swendsen J, Auriacombe M. Ecological momentary assessment in the investigation of craving and substance use in daily life: a systematic review. Drug and Alcohol Dependence. 148: 1-20. PMID 25637078 DOI: 10.1016/J.Drugalcdep.2014.12.024 |
0.785 |
|
| 2015 |
Demaret I, Quertemont E, Litran G, Magoga C, Deblire C, Auriacombe M, Dubois N, Roubaix JD, Charlier C, Lemaître A, Ansseau M, Senbanjo R, Strang J, Fernández-Aranda F, Jiménez-Murcia S, et al. Front & Back Matter European Addiction Research. 21. DOI: 10.1159/000342515 |
0.546 |
|
| 2015 |
Auriacombe M, Denis CM, Rosa MAC, Collombat J, Serre F, Daulouede J, Fatseas M. Validity of the eating section for the modified addiction severity index Drug and Alcohol Dependence. 156: e12. DOI: 10.1016/J.Drugalcdep.2015.07.951 |
0.744 |
|
| 2015 |
Serre F, Fatseas M, Swendsen J, Auriacombe M. Does craving intensity influence cue exposure reports? An ecological momentary assessment study in patients with alcohol, tobacco, cannabis and heroin use disorder Drug and Alcohol Dependence. 156: e201. DOI: 10.1016/J.Drugalcdep.2015.07.542 |
0.786 |
|
| 2015 |
Rosa MAC, Collombat J, Denis CM, Alexandre J, Serre F, Auriacombe M, Fatseas M. Overlap between food addiction and DSM-5 eating disorders in a treatment seeking sample Drug and Alcohol Dependence. 156: e192. DOI: 10.1016/J.Drugalcdep.2015.07.517 |
0.785 |
|
| 2015 |
Lhommeau N, Alexandre J, Mete D, Fatseas M, Auriacombe M. Characteristics of gamblers choosing self-exclusion from casinos: A prospective study in a French overseas territory Drug and Alcohol Dependence. 156: e127. DOI: 10.1016/J.Drugalcdep.2015.07.350 |
0.571 |
|
| 2015 |
Hurmic H, Debrabant R, Kervran C, Serre F, Auriacombe M, Fatseas M. ADHD and substance use disorders: Subtype and gender differences Drug and Alcohol Dependence. 156: e100-e101. DOI: 10.1016/J.Drugalcdep.2015.07.1190 |
0.773 |
|
| 2015 |
Fatseas M, Collombat J, Rosa MAC, Denis CM, Alexandre J, Debrabant R, Serre F, Auriacombe M. Measuring “craving” in food addiction: Type, frequency, intensity Drug and Alcohol Dependence. 156: e66. DOI: 10.1016/J.Drugalcdep.2015.07.1099 |
0.729 |
|
| 2015 |
Duburque C, Canva V, Auriacombe M, Djomboue P, Hernout B, Lucidarme D, Harbonnier J. A 3 year follow-up of HCV infection in opioid use disorder patients in treatment Drug and Alcohol Dependence. 156: e60. DOI: 10.1016/J.Drugalcdep.2015.07.1081 |
0.305 |
|
| 2015 |
Serre F, Fatseas M, Swendsen J, Auriacombe M. Corrigendum to “Ecological momentary assessment in the investigation of craving and substance use in daily life: A systematic review” Drug and Alcohol Dependence 148 (2015) 1–20 Drug and Alcohol Dependence. 154: 305-314. DOI: 10.1016/J.Drugalcdep.2015.03.001 |
0.789 |
|
| 2015 |
Serre F, Fatseas M, Swendsen J, Auriacombe M. Are sleep disturbances associated with craving intensity? What is the influence of psychiatric comorbidity and type of substance on this relationship? A computerized ambulatory monitoring study in patients beginning treatment for addiction Drug and Alcohol Dependence. 146: e94. DOI: 10.1016/J.Drugalcdep.2014.09.623 |
0.761 |
|
| 2015 |
Kervran C, Serre F, Fatseas M, Debrabant R, Trouba C, Taillard J, Philip P, Auriacombe M. Sleep quality in patients with SUD and behavioral addictions assessed by actigraphy: A prospective study Drug and Alcohol Dependence. 146: e156-e157. DOI: 10.1016/J.Drugalcdep.2014.09.343 |
0.74 |
|
| 2015 |
Hurmic H, Debrabant R, Serre F, Fatseas M, Alix M, Auriacombe M. Frequency and intensity of craving among addicted patients during outpatient treatment Drug and Alcohol Dependence. 146: e145. DOI: 10.1016/J.Drugalcdep.2014.09.312 |
0.75 |
|
| 2015 |
Fatseas M, Hurmic H, Debrabant R, Serre F, Auriacombe M. Substance use patterns associated with adult ADHD in SUD treatment-seeking patients: Results from the aquitaine addiction cohort study Drug and Alcohol Dependence. 146: e274-e275. DOI: 10.1016/J.Drugalcdep.2014.09.213 |
0.768 |
|
| 2015 |
Denis CM, Fatseas M, Beltran V, Daulouede J, Auriacombe M. Impact of 20 years harm reduction policy on HIV and HCV among opioid users not in treatment Drug and Alcohol Dependence. 146: e261. DOI: 10.1016/J.Drugalcdep.2014.09.177 |
0.584 |
|
| 2015 |
Daulouède J, Denis CM, Fatseas M, Beltran V, Auriacombe M. Risk-taking behavior over 36-month follow-up treatment in outpatient opioid maintenance treatment program Drug and Alcohol Dependence. 146: e258. DOI: 10.1016/J.Drugalcdep.2014.09.168 |
0.596 |
|
| 2015 |
Alexandre J, Fatseas M, Bouju G, Legauffre C, Valleur M, Magalon D, Chereau-Boudet I, Gorsane M, Auriacombe M, Hardouin J, Venisse J, Grall-Bronnec M. Gambling behavior among gamblers with and without attention deficit/hyperactivity disorder Drug and Alcohol Dependence. 146: e205-e206. DOI: 10.1016/J.Drugalcdep.2014.09.027 |
0.617 |
|
| 2015 |
Skutle A, Bu ETH, Jellestad FK, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, Auriacombe M, et al. Early developmental, temperamental and educational problems in 'substance use disorder' patients with and without ADHD: Does ADHD make a difference? Addictive Behaviors Reports. 2: 13-18. DOI: 10.1016/j.abrep.2015.03.001 |
0.587 |
|
| 2014 |
Auriacombe M, Denis C, Fatséas M. Commentary on Scharkow etal. (2014): Welcomed and yet to come. Are we looking at what we are looking for? Addiction. 109: 1918-1919. PMID 25297961 DOI: 10.1111/Add.12723 |
0.666 |
|
| 2014 |
Lofwall MR, Martin J, Tierney M, Fatséas M, Auriacombe M, Lintzeris N. Buprenorphine diversion and misuse in outpatient practice. Journal of Addiction Medicine. 8: 327-32. PMID 25221985 DOI: 10.1097/Adm.0000000000000029 |
0.601 |
|
| 2014 |
Petry NM, Rehbein F, Gentile DA, Lemmens JS, Rumpf HJ, Mößle T, Bischof G, Tao R, Fung DS, Borges G, Auriacombe M, GonzálezIbáñez A, Tam P, O'Brien CP. Moving internet gaming disorder forward: A reply. Addiction (Abingdon, England). 109: 1412-3. PMID 25103100 DOI: 10.1111/Add.12653 |
0.322 |
|
| 2014 |
Petry NM, Rehbein F, Gentile DA, Lemmens JS, Rumpf HJ, Mößle T, Bischof G, Tao R, Fung DS, Borges G, Auriacombe M, González Ibáñez A, Tam P, O'Brien CP. An international consensus for assessing internet gaming disorder using the new DSM-5 approach. Addiction (Abingdon, England). 109: 1399-406. PMID 24456155 DOI: 10.1111/Add.12457 |
0.372 |
|
| 2014 |
van de Glind G, Konstenius M, Koeter MW, van Emmerik-van Oortmerssen K, Carpentier PJ, Kaye S, Degenhardt L, Skutle A, Franck J, Bu ET, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, ... ... Auriacombe M, et al. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug and Alcohol Dependence. 134: 158-66. PMID 24156882 DOI: 10.1016/J.Drugalcdep.2013.09.026 |
0.376 |
|
| 2014 |
van Emmerik-van Oortmerssen K, van de Glind G, Koeter MW, Allsop S, Auriacombe M, Barta C, Bu ET, Burren Y, Carpentier PJ, Carruthers S, Casas M, Demetrovics Z, Dom G, Faraone SV, Fatseas M, et al. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction (Abingdon, England). 109: 262-72. PMID 24118292 DOI: 10.1111/Add.12370 |
0.659 |
|
| 2014 |
Petry NM, Blanco C, Auriacombe M, Borges G, Bucholz K, Crowley TJ, Grant BF, Hasin DS, O'Brien C. An overview of and rationale for changes proposed for pathological gambling in DSM-5. Journal of Gambling Studies / Co-Sponsored by the National Council On Problem Gambling and Institute For the Study of Gambling and Commercial Gaming. 30: 493-502. PMID 23526033 DOI: 10.1007/S10899-013-9370-0 |
0.336 |
|
| 2014 |
Debrabant R, Fatseas M, Denis C, Taillard J, Philip P, Auriacombe M. Qualité subjective du sommeil chez des sujets dépendants aux opiacés traités par méthadone ou buprénorphine MéDecine Du Sommeil. 11: 34-35. DOI: 10.1016/J.Msom.2014.01.082 |
0.669 |
|
| 2014 |
Serre F, Fatseas M, Swendsen J, Taillard J, Philip P, Auriacombe M. Relation entre problèmes de sommeil et envie de consommer (craving) chez des sujets dépendants en début de prise en charge pour leur addiction MéDecine Du Sommeil. 11: 34. DOI: 10.1016/J.Msom.2014.01.081 |
0.731 |
|
| 2014 |
Swendsen J, Serre F, Fatseas M, Auriacombe M. A systematic review of studies exploring craving, its moderators, and the link with substance use in daily life using Ecological Momentary Assessment (EMA) Drug and Alcohol Dependence. 140: e221. DOI: 10.1016/J.Drugalcdep.2014.02.613 |
0.788 |
|
| 2014 |
Serre F, Fatseas M, Swendsen J, Auriacombe M. Does craving predict substance use for different substance use disorders? An ecological momentary assessment study in patients with alcohol, tobacco, cannabis and heroin dependence Drug and Alcohol Dependence. 140: e202-e203. DOI: 10.1016/J.Drugalcdep.2014.02.564 |
0.794 |
|
| 2014 |
Fleury B, Denis CM, Nalpas B, Crapelet M, Auriacombe M. Patient motivation and 12-month treatment outcome in alcohol use disorder outpatients in France Drug and Alcohol Dependence. 140: e61. DOI: 10.1016/J.Drugalcdep.2014.02.185 |
0.389 |
|
| 2014 |
Fatseas M, Serre F, Swendsen J, Auriacombe M. Does cue type matter for craving? Comparison of substance-specific and person-specific cues using mobile technologies Drug and Alcohol Dependence. 140: e57. DOI: 10.1016/J.Drugalcdep.2014.02.175 |
0.739 |
|
| 2014 |
Auriacombe M, Denis CM, Beltran V, Alexandre J, Debrabant R, Serre F, Daulouede J, Fatseas M. 10-years outcome of methadone- and buprenorphine-maintained patients. Mortality, quality of life and substance use Drug and Alcohol Dependence. 140: e8. DOI: 10.1016/J.Drugalcdep.2014.02.043 |
0.757 |
|
| 2013 |
Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM, Schuckit M, Grant BF. DSM-5 criteria for substance use disorders: recommendations and rationale. The American Journal of Psychiatry. 170: 834-51. PMID 23903334 DOI: 10.1176/Appi.Ajp.2013.12060782 |
0.43 |
|
| 2013 |
Denis C, Lavie E, Fatseas M, Auriacombe M. WITHDRAWN: Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings The Cochrane Database of Systematic Reviews. 6. PMID 23780682 |
0.772 |
|
| 2013 |
Denis C, Fatseas M, Lavie E, Auriacombe M. WITHDRAWN: Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings The Cochrane Database of Systematic Reviews. 6. PMID 23780681 DOI: 10.1002/14651858.Cd005194.Pub3 |
0.765 |
|
| 2013 |
van de Glind G, van den Brink W, Koeter MW, Carpentier PJ, van Emmerik-van Oortmerssen K, Kaye S, Skutle A, Bu ET, Franck J, Konstenius M, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, ... ... Auriacombe M, et al. Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug and Alcohol Dependence. 132: 587-96. PMID 23660242 DOI: 10.1016/J.Drugalcdep.2013.04.010 |
0.354 |
|
| 2013 |
Hasin DS, Auriacombe M, Borges G, Bucholz K, Budney A, Crowley T, Grant BF, O'Brien C, Petry NM, Schuckit M, Wall MM. The DSM-5 field trials and reliability of alcohol use disorder. The American Journal of Psychiatry. 170: 442-3. PMID 23545795 DOI: 10.1176/Appi.Ajp.2013.13010032 |
0.36 |
|
| 2012 |
Bosc E, Fatséas M, Alexandre JM, Auriacombe M. [Similarities and differences between pathological gambling and substance dependance: A clarification]. L'Encephale. 38: 433-9. PMID 23062458 DOI: 10.1016/J.Encep.2012.02.004 |
0.612 |
|
| 2012 |
Serre F, Fatseas M, Debrabant R, Alexandre JM, Auriacombe M, Swendsen J. Ecological momentary assessment in alcohol, tobacco, cannabis and opiate dependence: a comparison of feasibility and validity. Drug and Alcohol Dependence. 126: 118-23. PMID 22647899 DOI: 10.1016/J.Drugalcdep.2012.04.025 |
0.776 |
|
| 2012 |
Fatseas M, Debrabant R, Auriacombe M. The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders. Current Opinion in Psychiatry. 25: 219-25. PMID 22449768 DOI: 10.1097/Yco.0B013E3283523D7C |
0.647 |
|
| 2012 |
Denis C, Fatséas M, Beltran V, Bonnet C, Picard S, Combourieu I, Daulouède JP, Auriacombe M. Validity of the self-reported drug use section of the Addiction Severity Index and associated factors used under naturalistic conditions. Substance Use & Misuse. 47: 356-63. PMID 22216906 DOI: 10.3109/10826084.2011.640732 |
0.587 |
|
| 2012 |
Malivert M, Fatséas M, Denis C, Langlois E, Auriacombe M. Effectiveness of therapeutic communities: a systematic review. European Addiction Research. 18: 1-11. PMID 21997500 DOI: 10.1159/000331007 |
0.686 |
|
| 2012 |
Fatseas M, Denis C, Serre F, Dubernet J, Daulouède JP, Auriacombe M. Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy. Aids and Behavior. 16: 2082-90. PMID 21983799 DOI: 10.1007/S10461-011-0054-4 |
0.766 |
|
| 2012 |
Denis C, Fatséas M, Auriacombe M. Analyses related to the development of DSM-5 criteria for substance use related disorders: 3. An assessment of Pathological Gambling criteria Drug and Alcohol Dependence. 122: 22-27. PMID 21962725 DOI: 10.1016/J.Drugalcdep.2011.09.006 |
0.742 |
|
| 2011 |
Fatseas M, Denis C, Massida Z, Verger M, Franques-Rénéric P, Auriacombe M. Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals. Biological Psychiatry. 70: 720-7. PMID 21741031 DOI: 10.1016/J.Biopsych.2011.05.015 |
0.715 |
|
| 2011 |
Denis C, Langlois E, Fatséas M, Auriacombe M, Auriacombe PM. Un modèle français de Communauté Thérapeutique ? Les communautés thérapeutiques expérimentales : Consensus des professionnels Psychotropes. 17: 85. DOI: 10.3917/Psyt.173.0085 |
0.671 |
|
| 2010 |
Fatséas M, Denis C, Lavie E, Auriacombe M. Relationship between anxiety disorders and opiate dependence- A systematic review of the literature. Implications for diagnosis and treatment Journal of Substance Abuse Treatment. 38: 220-230. PMID 20116963 DOI: 10.1016/J.Jsat.2009.12.003 |
0.799 |
|
| 2009 |
Le Bec PY, Fatséas M, Denis C, Lavie E, Auriacombe M. [Cannabis and psychosis: search of a causal link through a critical and systematic review]. L'Encephale. 35: 377-85. PMID 19748375 DOI: 10.1016/J.Encep.2008.02.012 |
0.778 |
|
| 2009 |
Fatséas M, Lavie E, Denis C, Auriacombe M. Self-perceived motivation for benzodiazepine use and behavior related to benzodiazepine use among opiate-dependent patients Journal of Substance Abuse Treatment. 37: 407-411. PMID 19339146 DOI: 10.1016/J.Jsat.2009.03.006 |
0.785 |
|
| 2009 |
Lavie E, Fatséas M, Denis C, Auriacombe M. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: Correlates of use, abuse and dependence Drug and Alcohol Dependence. 99: 338-344. PMID 18824311 DOI: 10.1016/J.Drugalcdep.2008.07.017 |
0.802 |
|
| 2008 |
Lavie E, Fatséas M, Daulouède JP, Denis C, Dubernet J, Cattan L, Auriacombe M. Comparison of prescriber evaluations and patient-directed self-reports in office-based practice for buprenorphine treatment of opiate-dependent individuals in France, 2002. Patient Preference and Adherence. 2: 369-78. PMID 19920984 DOI: 10.2147/Ppa.S4136 |
0.795 |
|
| 2007 |
Fatseas M, Auriacombe M. Why buprenorphine is so successful in treating opiate addiction in France. Current Psychiatry Reports. 9: 358-64. PMID 17915074 DOI: 10.1007/S11920-007-0046-2 |
0.604 |
|
| 2006 |
Denis C, Lavie E, Fatséas M, Auriacombe M. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings Cochrane Database of Systematic Reviews (Online). 3. PMID 16856093 DOI: 10.1002/14651858.Cd005336.Pub2 |
0.801 |
|
| 2006 |
Denis C, Fatséas M, Lavie E, Auriacombe M. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. The Cochrane Database of Systematic Reviews. CD005194. PMID 16856084 DOI: 10.1002/14651858.CD005194.pub2 |
0.788 |
|
| 2006 |
Fatséas M, Lavie E, Denis C, Franques-Rénéric P, Tignol J, Auriacombe M. [Benzodiazepine withdrawal in subjects on opiate substitution treatment]. Presse Medicale (Paris, France : 1983). 35: 599-606. PMID 16614601 DOI: 10.1016/S0755-4982(06)74647-4 |
0.786 |
|
| 2006 |
Tignol J, Martin-Guehl C, Aouizerate B, Grabot D, Auriacombe M. Social phobia and premature ejaculation: a case-control study. Depression and Anxiety. 23: 153-7. PMID 16502416 DOI: 10.1002/Da.20159 |
0.579 |
|
| 2005 |
Denis C, Fatseas M, Lavie E, Auriacombe M. Pharmacological interventions for benzodiazepine dependence management among benzodiazepine users in outpatient settings Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.Cd005194 |
0.76 |
|
| 2004 |
Auriacombe M, Fatséas M, Dubernet J, Daulouède JP, Tignol J. French field experience with buprenorphine. The American Journal On Addictions. 13: S17-28. PMID 15204673 DOI: 10.1080/10550490490440780 |
0.615 |
|
| 2004 |
Aouizerate B, Pujol H, Grabot D, Faytout M, Suire K, Braud C, Auriacombe M, Martin D, Baudet J, Tignol J. Body dysmorphic disorder in a sample of cosmetic surgery applicants. European Psychiatry : the Journal of the Association of European Psychiatrists. 18: 365-8. PMID 14643566 DOI: 10.1016/J.Eurpsy.2003.02.001 |
0.54 |
|
| 2004 |
Lavie E, Fatseas M, Messiah A, Franques P, Tignol J, Auriacombe M. P8-8 Facteurs associés à la consommation de benzodiazépines chez des patients traités par buprénorphine pour une dépendance aux opiacés (Aquitaine, France, 2001-2004) Revue D'éPidéMiologie Et De Santé Publique. 52: 109-110. DOI: 10.1016/S0398-7620(04)99304-2 |
0.737 |
|
| 2003 |
Auriacombe M, Fatseas M, Franques-Rénéric P, Daulouède JP, Tignol J. [Substitution therapy in drug addictions]. La Revue Du Praticien. 53: 1327-34. PMID 12920942 |
0.594 |
|
| 2002 |
Loustauneau A, Auriacombe M, Daulouede JP, Tignol J. [Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature]. Annales De Medecine Interne. 153: 2S31-6. PMID 12518080 |
0.741 |
|
| 2001 |
Mattick RP, Ali R, Auriacombe M, Davoli M, Faggiano F, Farrell M, Ferri M, Ling W. Cochrane Drugs and Alcohol Group: the development of systematic reviews of treatment outcome. Alcohol and Alcoholism (Oxford, Oxfordshire). 36: 109-11. PMID 11259206 DOI: 10.1093/Alcalc/36.2.109 |
0.31 |
|
| 1996 |
Auriacombe M. Buprenorphine in the treatment of opiate addiction. European status European Psychiatry. 11: 234s. DOI: 10.1016/0924-9338(96)88699-8 |
0.303 |
|
| 1995 |
Auriacombe M, Grabot D, Daulouède JP, Vergnolle JP, O'Brien C, Tignol J. A naturalistic follow-up study of French-speaking opiate-maintained heroin-addicted patients: effect on biopsychosocial status. Journal of Substance Abuse Treatment. 11: 565-8. PMID 7884840 DOI: 10.1016/0740-5472(94)90008-6 |
0.339 |
|
| 1993 |
Gariti P, Auriacombe M, Incmikoski R, McLellan AT, Patterson L, Dhopesh V, Mezochow J, Patterson M, O'Brien C. A randomized double-blind study of neuroelectric therapy in opiate and cocaine detoxification. Journal of Substance Abuse. 4: 299-308. PMID 1458046 DOI: 10.1016/0899-3289(92)90037-X |
0.322 |
|
| 1992 |
Woody GE, Auriacombe M. Drug abuse treatment Current Opinion in Psychiatry. 5: 420-425. DOI: 10.1097/00001504-199206000-00014 |
0.309 |
|
| Show low-probability matches. |